http://jn.nutrition.org/content/suppl/2007/11/29/137.12.2737.
DC1.html
Abstract
commercially available encapsulated juice powder concentrate (JPC) could influence indicators of oxidative stress,
immunity, and illness. Trained men (n 41; 34 6 5 y; maximum oxygen uptake 55 6 7 mLkg21min21) from a
homogenous police Special Forces unit were randomly assigned in a double blind manner to either JPC (n 21) or placebo
(n 20). We used multiple 7-d food records to assess dietary intake and found inadequate mean daily fruit and vegetable
consumption (3.2 6 1.2 servings). The group physician documented all duty days lost due to illness. We collected plasma
at baseline and study wk 4, 8, 16, and 28 for analysis of carbonyl groups on protein (CP) and TNFa. Over the 28-wk
investigation, CP was lower in the JPC group, with both a treatment and a time x treatment interaction (P , 0.05).
Concentrations of both CP and TNFa at 16 and 28 wk were lower in the JPC than in the placebo group (P , 0.001). TNFa
increased during the first 8 wk followed by a decrease in both groups for the following 20 wk (P , 0.001). Over the final 20
wk of the study, the placebo group tended to have more days of illness than the JPC group (P 0.068). These data
suggest beneficial JPC effects with regard to reduction of duty days lost due to illness and reduction of CP and TNFa
concentrations in this group of trained men over 28 wk. J. Nutr. 137: 27372741, 2007.
Introduction
In Europe, the WHO suggests adults consume 400 g/d of fruit
and nonstarchy vegetables (1) and Denmark recommends a
minimum of 600 g or 6 servings per day (2). In North America,
the United States recommends 513 servings of fruits and
vegetables each day, in proportion to total energy intake (3), and
Canada recommends 810 servings for adult males under age
50 y (4). These variable recommendations show a minimum
daily consumption of 5 or more servings of fruits and vegetables
is common public health advice. Dietary produce provide an
important source of phytochemicals and antioxidant nutrients,
along with water, fiber, and carbohydrates. Epidemiology observations have suggested that increased consumption of fruits and
vegetables is associated with a decreased risk of chronic
1
Supported by a cooperative international research grant from NSA (Collierville,
TN) to the Medical University of Graz (project no. 679) and the Styrian Health
Association, Graz, Austria.
2
Author disclosures: M. Lamprecht, K. Oettl, G. Schwaberger, P. Hofmann, and
J. F. Greilberger, no conflicts of interest.
3
Supplemental Tables 13 and Supplemental Figure 1 are available with the
online posting of this paper at jn.nutrition.org.
* To whom correspondence should be addressed. E-mail: manfred.lamprecht@
meduni-graz.at.
2737
Phytonutrients from plant foods provide numerous antioxidants. We hypothesized that supplementation for 28 wk with a
Lamprecht et al.
reagent, as previously described (19), expressed in units/mg Hb. Analytical inter-assay CV were #5.6% for SOD and #9.2% for GPx.
Statistical analysis. We used SPSS version 12.0 for statistical analysis.
Data are presented as means 6 SD. Significance was set at P , 0.05.
Power analysis and sample size calculation based on previous work with
CP (8) indicated 20 subjects per group were adequate for statistical
power of ;85% with a 0.05. Comparison of group baseline characteristics and food intake data used a t test. Group comparison of
nutrient analysis data used 1-way ANOVA and duty days lost due to
illness used the binomial test. We analyzed data obtained for CP, TNFa,
IL-6, SOD, and GPx using a 5 (time) 3 2 (treatment) repeated measures
ANOVA with grouping factors to show group differences over time.
When equal variance failed, a comparison was made by the MannWhitney rank sum test. To evaluate differences between treatments at
specific time points, additional analysis used t tests. We used Pearson
correlation coefficient and regression analysis to evaluate bivariate
relationships.
Results
TABLE 1
Variables
n
Age, y
Height, cm
Weight, kg
Total body fat, %
Lean body mass, kg
VO2max, mLkg21min21
Maximum workload, W
Glucose, mmol/L
Hb, g/L
Iron, mmol/L
Cholesterol, mmol/L
Triglycerides, mmol/L
Albumin, g/L
C-reactive protein, mg/L
Uric acid, mmol/L
1
2
Reference range2
(3.96.1)
(136172)
(1432)
(,5.85)
(,1.80)
(4060)
(0.530)
(120420)
JPC
34.3
183.2
83.6
12.9
72.7
58.4
345
4.8
156
19
4.45
0.86
43
8
210
21
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
Placebo
5.1
11.4
8.1
3.8
6.6
12.5
35
1.1
28
6
1.15
0.48
15
19
100
33.8
180.8
79.8
12.4
69.9
54.8
335
4.6
158
18
4.70
0.94
44
9
290
20
6 5.7
6 8.6
6 5.4
6 2.2
6 4.7
6 9.3
6 25
6 1.2
6 31
67
6 1.00
6 0.62
6 19
6 15
6 80
Values are means 6 SD and did not differ between the groups, P . 0.05 (t test).
Reference range for clinical chemistry variables (20).
Discussion
This was an investigation of a homogenous population of fit men
who shared many group meals and often slept in the Cobra
group house. The results of this study indicate daily supplementation with JPC for 28 wk protected plasma proteins against free
radical-induced oxidative stress compared with a placebo, as
demonstrated by decreased CP concentrations. The immune and
inflammatory marker, TNFa, was also reduced in the JPC group.
The difference was most pronounced from wk 8 to wk 28
(January to June) in conjunction with the additional stress of
increased duty hours. The stable activities of antioxidant enzymes GPx and SOD across the study term, combined with
reduced concentrations of CP, suggest enhanced antioxidant
status in the JPC group as previously reported by others (10,21).
The combination of fruit and nonstarchy vegetable servings
averaged 3.2/d in both groups (Supplemental Table 2), below the
lowest public health recommendation (1). Dietary intake analysis found folate was low but equivalent in the groups at
TABLE 2
n
Overall episodes of illness, n/28 wk
Overall duty days lost due to illness, d/28 wk
Days lost due to illness baselinewk 8, d/08wk
Days lost due to illness wk 8wk 28, d/828wk
JPC
Placebo
P-value
21
17
108
67
41
20
22
134
73
61
.0.1
0.089
.0.1
0.068
2739
TABLE 3
Comparison of plasma CP, TNFa, and RBC SOD and GPx in physically active men consuming JPC or placebo for 28 wk1
2-way ANOVA P-values
Variable
Group
JPC
Placebo
JPC
Placebo
JPC
Placebo
JPC
Placebo
Wk 0
0.39
0.38
1.87
1.29
17.7
16.2
212
195
6 0.05
6 0.05
6 0.64
6 0.35
6 6.3
6 5.8
6 39
6 48
Wk 4
0.33 6
0.35 6
2.26 6
2.01 6
16.3 6
14.8 6
201 6
191 6
0.06
0.04
0.33
0.36
6.2
5.8
26
58
Wk 8
0.32 6
0.35 6
3.50 6
3.85 6
10.4 6
11.1 6
168 6
177 6
0.05
0.03
0.39
0.44
5.8
6.5
41
29
Wk 16
0.27*
0.38
0.63*
2.01
18.0
18.0
202
186
6
6
6
6
6
6
6
6
0.03
0.06
0.53
0.48
5.4
5.9
37
33
Wk 28
0.29*
0.49
1.24*
2.51
17.9
16.8
214
205
6 0.04
6 0.05
6 0.46
6 0.72
6 6.3
6 5.5
6 32
6 26
Time
Treatment
Time 3 treatment
0.112
0.001
0.004
0.008
0.256
0.092
,0.0001
0.932
0.869
0.011
0.609
0.919
Values are means 6 SD, n 21 (JPC) or 20 (placebo). *Different from placebo at that time, P , 0.05 (t-test).
2740
Lamprecht et al.
Acknowledgments
The authors thank the Einsatzkommando Cobra Sud Commander, Colonel Manfred Komericky, for cooperation and
access to this cohort.
Literature Cited
1.
2.
3.
4.
5.
6.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
2741
7.